TASTE MASKING AND FORMULATION DEVELOPMENT & EVALUATION OF MOUTH DISSOLVING TABLETS OF LEVOCETRIZINE DIHYDROCHLORIDE
Abstract
Levocetrizine dihydrochloride is the active R (-) enantiomer of cetrizine. It is an orally active and selective H1 receptor antagonist used medically as an Antiallergic. Allergic rhinitis is a symptomatic disorder of the nose induced by inflammation mediated by immunoglobulin E (IgE) in the membrane lining the nose after allergen exposure. Thus formulating Levocetirizine dihydrochloride into a mouth dissolving tablets would provide fast relief. Levocetirizine dihydrochloride is bitter in taste so the Kyron T-134 (ion exchange resin) was used to mask the taste and formulated a mouth dissolving tablets using drug resin complex. Results show that effective taste masking is achieved for Levocetrizine dihydrocloride by preparing drug-resin complex using Kyron T-134. The tablets have evaluated for the drug content, weight variation, and water absorption ratio, wetting time, in vitro disintegration, hardness, friability, thickness uniformity and in-vitro dissolution. The tablets disintegrated in- vitro within 21 to 33 seconds. . The % drug content of tablets in all formulations was found to be between 90-110% which complied with limits established in Indian Pharmacopoeia. In vitro drug release profile of tablets is shown 99% drug release in 10 minutes. The results show that Levocetirizine dihydrochloride is successfully formulated into a mouth dissolving tablet.
Key words: Levocetirizine dihydrochloride, Allergic rhinitis, Super disintegrants, Ion exchange resin, Mouth dissolving tablets.DOI
https://doi.org/10.22270/jddt.v3i3.514Published


How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).